China GMP Qualität Fabrik Direktversorgung 99% Reinheit Mounjaro Peptide Rohes lyophilisiertes Pulver CAS 2023788-19-2

Klassifikation
Aminosäure
Funktion
Keeping Gesundheit und Wachstum fördern
Aussehen
Pulver
Versandzeit
Innerhalb von 24 Stunden nach Zahlungseingang
Richtlinie
Wiederlieferung
Reinheit
99 %
Transportpaket
Discreet and Disguised
Spezifikation
Qualified
Warenzeichen
WHOK
Herkunft
China
HS-Code
3001200020
Produktionskapazität
50 Mt/Year
Referenzpreis
$ 9.00 - 45.00

Produktbeschreibung

 

Product Description

Product Name Tirzepatide,GIP,GLP-1
CAS NO. 2023788-19-2
Appearance White Powder
Purity 99% or customized
Application Drug peptides
Usage Tirzepatide injection is used to treat type 2 diabetes.

Product Introduction

Tirzepatide (Mounjaro) is a novel medication indicated as an adjunct to diet and exercise in the treatment of patients with type 2 diabetes mellitus. Tirzepatide is a dual receptor agonist, acting on glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) to lower blood glucose levels.

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 agonist that has been studied recently as a treatment for patients with noncirrhotic NASH (SYNERGY-NASH, NCT04166773) given its association with significant weight loss and improvement in features of metabolic syndrome in diabetes trials.

Product Usage

The addition of GIP which anatagonizes the central effects of GLP-1 to cause nausea is designed to improve tolerability and also allow for more aggressive dosing with increased systemic exposure. A recent post-hoc analysis showed significantly decreased NASH-related biomarkers and increased adiponectin in patients with T2DM

The weight-reducing actions of the GIPR-GLP1R co-agonist tirzepatide.Considerable interest is focused on the mechanisms of action of tirzepatide, a highly effective GIPR-GLP1R co-agonist that produces superior reductions in HbA1c and body weight, relative to that achieved with 1 mg once weekly of semaglutide in people with T2D. The GIPR is expressed in multiple regions of the mouse and human brain, in subsets of neurons and glial cells, with some hypothalamic and hindbrain cells exhibiting co-expression of the GIPR and GLP1R. Chemogenetic activation of GIPR + cells in the mouse hypothalamus acutely reduced food intake; however, co-administration of exendin-4 did not produce an additive reduction of food intake when compared to either intervention alone.

Therapy with tirzepatide, 5-15 mg once weekly produces 8-12% body weight reduction in people with T2D, prompting ongoing development of tirzepatide as a weight loss agent for people with overweight or obesity. The importance of GIP for the weight loss properties of tirzepatide in humans is uncertain; however, tirzepatide failed to reduce body weight in Glp1r−/- mice, implicating a dominant role for the GLP1R in the weight loss observed with this agent. Glucose-dependent insulinotropic polypeptide (GIP) has been shown to reduce the extent of aversive responses induced by GLP-1 in mice and rats and decrease nausea and vomiting in the shrew.

Tags

Pharmaceutical Peptides   2023788-19-2, Buy Tirzepatide Powder, China Tirzepatide Powder, GIP Powder, GLP-1 Powder, Steroids Raw Powder, Tirzepatide Dosage, Tirzepatide Injection, Tirzepatide Peptides, Tirzepatide Powder, Tirzepatide Powder For Sale, Tirzepatide Price, Tirzepatide Raw, Tirzepatide Raw Powder, Tirzepatide Source, Tirzepatide Supplier, Tirzepatide Usage, Tirzepatide Vials

Our Market

China GMP Quality Factory Direct Supply 99% Purity Mounjaro Peptides Raw Lyophilized Powder CAS 2023788-19-2

Shipment Way

China GMP Quality Factory Direct Supply 99% Purity Mounjaro Peptides Raw Lyophilized Powder CAS 2023788-19-2

Research & Development

China GMP Quality Factory Direct Supply 99% Purity Mounjaro Peptides Raw Lyophilized Powder CAS 2023788-19-2

Our Advantages


 

 

DREAMKITCHEN.PT, 2023